Upgrade to SI Premium - Free Trial

CVS Health (CVS) PT Raised to $75 at BofA/Merrill Lynch

September 12, 2019 8:49 AM
BofA/Merrill Lynch analyst Michael Cherny raised the price target on CVS Health (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles